Sep 27, 2022

Ramiro Garzon, MD, To Lead Hematologic Cancers at Huntsman Cancer Institute and University of Utah Health

A national authority in hematology will soon lead Hematology and Hematological Malignancies at Huntsman Cancer Institute and University of Utah Health. Dr. Ramiro Garzon’s focus is patients with leukemia and researching the molecular mechanisms of these cancers. Garzon’s major focuses include developing new treatment for cancers that begin in blood forming tissue such as the bone marrow or in the cells of the immune system. He explains his research and clinical goals.

Dec 20, 2021

New Research Highlights Potential Role of Gas Plasma in Leukemia Treatment

A unique collection of tissue samples donated by people with chronic myeloid leukemia was the driving force behind the discovery of a potentially major new treatment approach for drug-resistant leukemia. The tissue samples were provided by cancer patients at Huntsman Cancer Institute.

Dec 01, 2021

Sequencing of Bone Marrow DNA May Predict Leukemia Relapse After CAR-T Therapy

In pediatric and young adult patients with acute lymphoblastic leukemia (ALL) treated with tisagenlecleucel (Kymriah), DNA sequencing-based detection accurately identified all patients who would eventually relapse, while other methods were less predictive, according to a study published in Blood Cancer Discovery, a journal of the American Association for Cancer Research.

Aug 30, 2021

Striking Out Cancer: Life after a Leukemia Diagnosis

Adam Whitt shares experiences about being a professional baseball pitcher and then being diagnosed with chronic myeloid (or myelogenous) leukemia. Now in remission, he is finding success in another sport – golf.

Aug 19, 2021

Research Identifies Genomic Markers of Aggressive Childhood Leukemias

New research published today in JAMA Oncology reports how two separate DNA changes appear to predict aggressive childhood leukemias when they occur in combination. This study illuminates genetic understanding of acute lymphoblastic leukemia in children with the worst outcomes, including relapse and/or death.

May 21, 2021

National Clinical Trials in Breast Cancer and Hematologic Cancers Open

Huntsman Cancer Institute highlights two examples of clinical trials at HCI exploring new innovations in cancer, including the I-SPY2 trial, studying new approaches for breast cancer treatment, and the SWOG CLL Study S1925, or EVOLVE CLL, an international study evaluating a new approach to chronic lymphocytic leukemia or small lymphocytic lymphoma.

Mar 03, 2021

Utah Researchers Illuminate Potential Precursors of Blood Cancers

Utah researchers report significant new insights into the development of blood cancers. Comparing DNA data in people with and without blood disorders, the researchers discovered genetic mutations in about 2% of the presumably healthy participants that were identical to those frequently observed in the cancer patients. These findings provide new clues about mutations that may initiate cancer development and those that may help cancer progress.

Jan 20, 2021

American Society of Hematology Selects Ami Patel to Receive ASH Scholar Award

HCI physician-scientist Ami Patel, MD, has been selected by the American Society of Hematology (ASH) to receive a Scholar Award for her research in leukemia. ASH Scholar Awards are one of ASH’s most prestigious research award programs. They provide financial support to fellows and junior faculty who have dedicated their careers to advancing the field of hematology research as they transition from training programs to careers as independent investigators.